Benzinga | Nov 9, 2021 04:46PM EST

ClearPoint Neuro Q3 EPS $(0.18) Misses $(0.16) Estimate, Sales $4.60M Beat $4.00M Estimate

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 100 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $4.60 million which beat the analyst consensus estimate of $4.00 million by 15.00 percent. This is a 30.72 percent increase over sales of $3.52 million the same period last year.